Prelude Therapeutics Inc — All Filings
358 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | — | 0000929638-26-001070 | Mar 19, 2026 | Mar 5, 2026 |
| 424B5 | 424B5 | 0001193125-26-104185 | Mar 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-104204 | Mar 12, 2026 | — |
| S-8 | S-8 | 0001193125-26-099442 | Mar 10, 2026 | — |
| 10-K | 10-K | 0001193125-26-099428 | Mar 10, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-099424 | Mar 10, 2026 | — |
| SCHEDULE 13G/A | — | 0000929638-26-000626 | Feb 13, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0001825005-26-000002 | Feb 5, 2026 | Feb 4, 2026 |
| 4 | PRIMARY DOCUMENT | 0001824633-26-000002 | Feb 5, 2026 | Feb 4, 2026 |
| 4 | PRIMARY DOCUMENT | 0001752888-26-000002 | Feb 5, 2026 | Feb 4, 2026 |
| 4 | PRIMARY DOCUMENT | 0001824632-26-000002 | Feb 5, 2026 | Feb 4, 2026 |
| 8-K | 8-K | 0001193125-26-034564 | Feb 3, 2026 | Jan 29, 2026 |
| 8-K | 8-K | 0001193125-26-008280 | Jan 9, 2026 | — |
| EFFECT | — | 9999999995-25-003796 | Dec 16, 2025 | — |
| S-3 | — | 0000929638-25-004572 | Dec 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-275871 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-275887 | Nov 12, 2025 | Sep 30, 2025 |
| 4 | PRIMARY DOCUMENT | 0001620368-25-000005 | Nov 7, 2025 | Nov 5, 2025 |
| 8-K | — | 0000929638-25-004115 | Nov 4, 2025 | Nov 3, 2025 |
| 3 | — | 0000929638-25-003930 | Oct 20, 2025 | Oct 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0001617541-25-000005 | Oct 20, 2025 | Oct 17, 2025 |
| 8-K | 8-K | 0001193125-25-241968 | Oct 17, 2025 | Oct 15, 2025 |
| 4 | PRIMARY DOCUMENT | 0001683913-25-000004 | Oct 7, 2025 | Oct 4, 2025 |
| 8-K | 8-K | 0001193125-25-208187 | Sep 19, 2025 | Sep 18, 2025 |
| 10-Q | 10-Q | 0000950170-25-108417 | Aug 14, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-108413 | Aug 14, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-005346 | Jul 8, 2025 | Jul 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004798 | Jun 13, 2025 | Jun 12, 2025 |
| 3 | 3 | 0000950170-25-086301 | Jun 13, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086307 | Jun 13, 2025 | Jun 12, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004797 | Jun 13, 2025 | Jun 12, 2025 |
| 8-K | 8-K | 0000950170-25-086170 | Jun 13, 2025 | Jun 11, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-059474 | Jun 13, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004786 | Jun 13, 2025 | Jun 12, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004790 | Jun 13, 2025 | Jun 12, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004795 | Jun 13, 2025 | Jun 12, 2025 |
| SCHEDULE 13G/A | — | 0000929638-25-001925 | May 15, 2025 | — |
| 8-K | 8-K | 0000950170-25-064531 | May 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-064566 | May 6, 2025 | Mar 31, 2025 |
| ARS | ARS | 0000950170-25-059559 | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-059555 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-059549 | Apr 29, 2025 | Jun 12, 2025 |
| 8-K | 8-K | 0000950170-25-058776 | Apr 25, 2025 | — |
| PRE 14A | PRE 14A | 0000950170-25-053323 | Apr 11, 2025 | Jun 12, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-003036 | Apr 7, 2025 | Apr 4, 2025 |
| 8-K | 8-K | 0000950170-25-046839 | Mar 28, 2025 | Mar 27, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-002778 | Mar 27, 2025 | Mar 25, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-002779 | Mar 27, 2025 | Mar 25, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-002697 | Mar 24, 2025 | Mar 20, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-002541 | Mar 18, 2025 | Mar 14, 2025 |